Press Releases

Filter Releases

Date	Title and Summary	View
Toggle SummaryMar 26, 2015	Onconova Therapeutics, Inc. Reports Recent Business Highlights and Fourth Quarter and Year-End 2014 Financial Results Company Outlines Key Objectives for 2015	View HTML Onconova Therapeutics, Inc. Reports Recent Business Highlights and Fourth Quarter and Year-End 2014 Financial Results 28.2 KB
Toggle SummaryMar 04, 2015	Onconova Therapeutics, Inc. to Present at 27th Annual ROTH Conference	View HTML Onconova Therapeutics, Inc. to Present at 27th Annual ROTH Conference 13.1 KB
Toggle SummaryFeb 02, 2015	Onconova Announces Clinical Development Plan for Rigosertib in Higher Risk Myelodysplastic Syndrome (HR-MDS) Patients After Failure of Treatment With Hypomethylating Agents (HMAs)	View HTML Onconova Announces Clinical Development Plan for Rigosertib in Higher Risk Myelodysplastic Syndrome (HR-MDS) Patients After Failure of Treatment With Hypomethylating Agents (HMAs) 19.1 KB
Toggle SummaryJan 30, 2015	Onconova Therapeutics, Inc. to Present at Upcoming Investor Conferences in February	View HTML Onconova Therapeutics, Inc. to Present at Upcoming Investor Conferences in February 13 KB
Toggle SummaryJan 12, 2015	Onconova Therapeutics Appoints Dr. Steven M. Fruchtman as Chief Medical Officer	View HTML Onconova Therapeutics Appoints Dr. Steven M. Fruchtman as Chief Medical Officer 18.1 KB
Toggle SummaryDec 07, 2014	Onconova Announces Data Presentation From Combination of Rigosertib and Azacitidine in MDS and Non-proliferative AML at the 2014 ASH Annual Meeting Results From Phase 1 Trial of Oral Rigosertib and Azacitidine Combination Indicate Encouraging Rate of Response in MDS and AML	View HTML Onconova Announces Data Presentation From Combination of Rigosertib and Azacitidine in MDS and Non-proliferative AML at the 2014 ASH Annual Meeting 19.2 KB
Toggle SummaryDec 07, 2014	Onconova Announces ONTIME Data Presentations at the 2014 ASH Annual Meeting Detailed Data From Phase 3 ONTIME Trial Presented on Rigosertib Activity and Biological Plausibility in MDS Subgroups	View HTML Onconova Announces ONTIME Data Presentations at the 2014 ASH Annual Meeting 19.2 KB
Toggle SummaryDec 05, 2014	Onconova Therapeutics to Host Analyst Event in New York City on December 12, 2014	View HTML Onconova Therapeutics to Host Analyst Event in New York City on December 12, 2014 13.7 KB
Toggle SummaryNov 13, 2014	Onconova Therapeutics, Inc. Reports Third Quarter 2014 Financial and Operational Results Nine Presentations to Highlight Programs Including rigosertib Phase 3 Trial at the ASH Annual Meeting	View HTML Onconova Therapeutics, Inc. Reports Third Quarter 2014 Financial and Operational Results 26.9 KB
Toggle SummaryNov 06, 2014	Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting	View HTML Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting 24.2 KB
Toggle SummarySep 03, 2014	Onconova Therapeutics, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference	View HTML Onconova Therapeutics, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference 12.5 KB
Toggle SummaryAug 13, 2014	Onconova Therapeutics, Inc. Reports Second Quarter 2014 Financial and Operational Results	View HTML Onconova Therapeutics, Inc. Reports Second Quarter 2014 Financial and Operational Results 29.1 KB
Toggle SummaryAug 06, 2014	Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2014 Financial Results and Conference Call	View HTML Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2014 Financial Results and Conference Call 12.8 KB
Toggle SummaryMay 12, 2014	Onconova Therapeutics, Inc. Reports First Quarter 2014 Financial and Operational Results	View HTML Onconova Therapeutics, Inc. Reports First Quarter 2014 Financial and Operational Results 26.7 KB
Toggle SummaryMay 06, 2014	Onconova Therapeutics, Inc. Announces Timing for First Quarter 2014 Financial Results and Conference Call	View HTML Onconova Therapeutics, Inc. Announces Timing for First Quarter 2014 Financial Results and Conference Call 12.8 KB